Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Rang in aandelen #33721
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Aandeelprijs
$0.4732
Laatst gesynchroniseerd: 2022-10-26
Marktkapitalisatie
$7.05M
Verandering (1 dag)
-0.03%
Verandering (1 jaar)
0.00%
Land
US
Handel GBS Inc. (GBS)

Categorie

Aandelsplitsingen voor GBS Inc. (GBS)
Het aandeel GBS Inc. (symbool: GBS) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 17, 2026.
Eén aandeel GBS dat vóór Aug 17, 2026 werd gekocht, staat nu gelijk aan 0 aandelen GBS.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US